Search Within

Edmund King Bartlett

Formats
  1. Journal Article (35)
  2. Meeting Abstract (24)
  3. Review (6)
  4. Miscellaneous (5)
  5. Correspondence (4)
  6. Editorial (3)
  7. Guidelines (1)
Groups
  1. CTCR Scholars (78)
  2. MSK Grad Students (78)
  3. Master of Science in Clinical and Translational Cancer Research (78)
  4. Melanoma Disease Management Team (78)
  5. Surgery (78)
  6. Department of Medicine (41)

More Groups

People
  1. Charlotte Ariyan (25)
  2. Daniel Coit (23)
  3. Michael Marchetti (19)
  4. Danielle Bello (15)
  5. Mary Brady (14)
  6. Ciara Kelly (12)

More People

Years
  1. 2025 (6)
  2. 2024 (7)
  3. 2023 (20)
  4. 2022 (14)
  5. 2021 (9)
  6. 2020 (14)

More Years

Publications
  1. Annals of Surgical Oncology (27)
  2. Journal of the American College of Surgeons (8)
  3. JAMA Dermatology (5)
  4. Journal of Surgical Oncology (5)
  5. Journal of the American Academy of Dermatology (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. Springer (27)
  2. Elsevier Science, Inc. (8)
  3. Wiley Blackwell (8)
  4. American Medical Association (7)
  5. American Society of Clinical Oncology (5)
  6. Oxford University Press (5)

More Publishers

Results (78)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Case report: Response to regional melphalan via limb infusion and systemic PD1 blockade in recurrent myxofibrosarcoma: A report of 2 cases
    Journal Article

    Bartlett, E. K.; D’Angelo, S. P.; Kelly, C. M.; Siegelbaum, R. H.; Fisher, C.; Antonescu, C. R.; Ariyan, C. E.
    Frontiers in Oncology (2021)

    Fulltext@MSK | Save
  • Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
    Meeting Abstract

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M.; Gounder, M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)
    Journal Article

    Broman, K. K.; Hughes, T.; Dossett, L.; Sun, J.; Kirichenko, D.; Carr, M. J.; Sharma, A.; Bartlett, E. K.; Nijhuis, A. A. G.; Thompson, J. F.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • Histologic subtype defines the risk and kinetics of recurrence and death for primary extremity/truncal liposarcoma
    Journal Article

    Bartlett, E. K.; Curtin, C. E.; Seier, K.; Qin, L. X.; Hameed, M.; Yoon, S. S.; Crago, A. M.; Brennan, M. F.; Singer, S.
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Surveillance of sentinel node-positive melanoma patients with reasons for exclusion from MSLT-II: Multi-institutional propensity score matched analysis
    Journal Article

    Broman, K. K.; Hughes, T. M.; Dossett, L. A.; Sun, J.; Carr, M. J.; Kirichenko, D. A.; Sharma, A.; Bartlett, E. K.; Nijhuis, A. A.; Thompson, J. F.; more...
    Journal of the American College of Surgeons (2021)

    Fulltext@MSK | Save
  • The emerging role of immunotherapy for the treatment of sarcoma
    Review

    Klemen, N. D.; Kelly, C. M.; Bartlett, E. K.
    Journal of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Sentinel lymph node biopsy for T1b melanoma: Balancing prognostic value and cost
    Journal Article

    Hu, Y.; Briggs, A.; Gennarelli, R. L.; Bartlett, E. K.; Ariyan, C. E.; Coit, D. G.; Brady, M. S.
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Cost-benefit implication of gene expression profiling and adjuvant therapy in stage IIIA melanoma
    Journal Article

    Hu, Y.; Briggs, A.; Marchetti, M. A.; Ariyan, C. E.; Coit, D. G.; Bartlett, E. K.
    Journal of the American College of Surgeons (2020)

    Fulltext@MSK | Save
  • Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma
    Correspondence

    Marchetti, M. A.; Dusza, S. W.; Bartlett, E. K.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • Gene expression profile-based risk modeling to select patients with melanoma who can avoid sentinel lymph node biopsy: Are we there yet?
    Correspondence

    Bartlett, E. K.; Marchetti, M. A.; Coit, D. G.
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save